A Double Blind, Placebo Controlled, Dose Escalation Trial of Glycerol Phenylbutyrate Corrector Therapy for Cystic Fibrosis
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 06 Aug 2017
At a glance
- Drugs Glycerol phenylbutyrate (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 28 Feb 2017 Planned initiation date changed from 1 Jun 2017 to 1 Aug 2017.
- 01 Sep 2016 Planned End Date changed from 1 Apr 2018 to 1 Apr 2020.